Showing results (521-530 of 1,123) with videos related to

Sort By:
Pageof 113
The Journal of Bone and Joint Surgery. American Volume|August 23, 2013
The direct and indirect costs to society of treatment for end-stage knee osteoarthritisDavid Ruiz, Lane Koenig, Timothy M Dall, et al.
Ugeskrift for Laeger|March 27, 2024
Camilla Dall-Jepsen, Anne Zahrtmann Møller, Louise Tram, et al.
BMJ Open Sport & Exercise Medicine|May 17, 2024
Atrial remodelling associated with sporting discipline, sex and duration in elite sports: a cross-sectional echocardiographic study among Danish elite athletesMikkel Aaroee, Susanne Glasius Tischer, Robin Christensen, et al.
Journal of Clinical Pharmacology|November 1, 2011
Pharmacokinetics and safety of coadministered oseltamivir and rimantadine in healthy volunteers: an open-label, multiple-dose, randomized, crossover studyGeorgina Cirrincione-Dall, Barbara J Brennan, Rosa M Ballester-Sanchis, et al.
American Journal of Preventive Medicine|February 22, 2011
Weight loss and lifetime medical expenditures: a case study with TRICARE prime beneficiariesTimothy M Dall, Yiduo Zhang, Shiping Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Growth hormone increases vascular cell adhesion molecule 1 expression: in vivo and in vitro evidenceTroels Krarup Hansen, Sanne Fisker, Rolf Dall, et al.
Folia Histochemica Et Cytochemica|January 1, 1981
Histochemical study of mucopolysaccharides in epidermal mucous cells and subjacent granular cells of Glossoscolex uruguayensis L. (Righi, 1978)V D Dall Pai, I R Santos Costa, A C Pacheco, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cellsPeter Dall, Isabell Herrmann, Bettina Durst, et al.
Health Affairs (Project Hope)|November 6, 2013
An aging population and growing disease burden will require a large and specialized health care workforce by 2025Timothy M Dall, Paul D Gallo, Ritasree Chakrabarti, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancerA du Bois, H G Meerpohl, H Madjar, et al.
Pageof 113